DMXAA and Its Effect on TNF Production in Human Blood Cells
Author Information
Author(s): M Philpott, WR Joseph, KE Crosier, BC Baguley, L-M Ching
Primary Institution: University of Auckland School of Medicine
Hypothesis
Can DMXAA induce TNF production in human peripheral blood leucocytes more effectively than FAA?
Conclusion
DMXAA can induce TNF production in human peripheral blood leucocytes, unlike FAA, indicating its potential as an effective anti-tumor agent.
Supporting Evidence
- DMXAA up-regulated TNF mRNA synthesis in 6 of 8 individuals tested.
- TNF protein levels increased in 11 of 15 samples after DMXAA treatment.
- FAA did not induce TNF production in any of the donors.
Takeaway
This study shows that a drug called DMXAA can help the body produce a substance that fights tumors, while another drug, FAA, does not work the same way.
Methodology
Human peripheral blood leucocytes were isolated and cultured with DMXAA, FAA, or LPS, and TNF production was measured using cytotoxicity assays and Northern blotting.
Potential Biases
Potential bias due to the small sample size and variability in individual responses.
Limitations
The study observed considerable variability in TNF response among individuals, which may affect the generalizability of the results.
Participant Demographics
Participants included 15 healthy individuals (8 female, 7 male, ages 16 to 65 years).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website